Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications: Out of specification for dissolution.
Products
  • Ranolazine Extended-Release Tablets 500mg
Where it was sold

Nationwide

Nationwide

Units affected
16,944 bottles
About this recall
Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur Dist - Dhar, Madhya Pradesh - 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-319-60.